Skip to search formSkip to main contentSkip to account menu

cisplatin/gemcitabine

Known as: gemcitabine cisplatin, cisplatin gemcitabine, CDDP/dFdC 
A chemotherapy combination used to treat malignant mesothelioma, advanced non-small cell lung cancer, advanced bladder cancer, advanced cervical… 
National Institutes of Health

Related topics

Related topics

4 relations
CisplatinGemcitabine hydrochlorideLY 188011gemcitabine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Clinical observation of docetaxel plus cisplatin versus gemcitabine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer
ObjectiveThe aim of this study was to evaluate the clinical efficacy and side effects of docetaxel/cisplatin regiment and… 
2011
2011
Effect of recombinant human endostatin on antitumor efficacy of paclitaxel/gemcitabine/cisplatin (TGP) chemotherapy in the treatment of advanced urothelial carcinoma.
265^ Background: Rh-endostatin is a new recombinant human endostatin that can inhibit tumor endothelial cell proliferation… 
2010
2010
ABC-03: A randomized, phase II/III study of cediranib (AZD2171) or placebo in combination with cisplatin/gemcitabine for patients with advanced biliary tract cancers.
TPS218 Background: The ABC-02 trial (Valle ASCO 2009, abstr. 4503), the largest ever randomized phase III trial in ABC to date… 
2009
2009
Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC)
2008
2008
Risk of symptomatic central nervous system (CNS) progression and secondary hemorrhage in patients with non-squamous non-small cell lung cancer (NSCLC) receiving bevacizumab (BV)-based first-line…
8114 Background: Preliminary data on the safety of Bv in subjects with advanced or metastatic NSCLC with previously treated brain… 
2008
2008
Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium
SummaryObjectives: Gemcitabine (G) plus cisplatin (C) is standard care for metastatic transitional cell carcinoma (TCC) of the… 
2008
2008
Resource utilization by non-small cell lung cancer histology: Results from the randomized, phase III trial of pemetrexed/cisplatin versus gemcitabine/cisplatin
2008
2008
The influence of sex on efficacy, toxicity and delivery of treatment in National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) non-small cell lung cancer (NSCLC) chemotherapy trials
8054 Background: Outcomes in lung cancer may differ by sex, with some studies reporting longer survival in women. Increased… 
2004
2004
Cholangiozelluläres Karzinom und Gallenblasenkarzinom
Risk factors for cholangiocellular and gallbladder carcinomas are bile stones and chronic inflammation of the biliary system… 
1997
1997
Rationale of a phase III study comparing a standard cisplatin regimen (mitomycin/ifosfamide/cisplatin) with cisplatin and gemcitabine in non-small cell lung cancer.
Cisplatin-based combination chemotherapy is currently considered the most active treatment for advanced non-small cell lung…